135 related articles for article (PubMed ID: 33644071)
1. Impaired Barrier Function and Immunity in the Colon of Aldo-Keto Reductase 1B8 Deficient Mice.
Wang X; Khoshaba R; Shen Y; Cao Y; Lin M; Zhu Y; Cao Z; Liao DF; Cao D
Front Cell Dev Biol; 2021; 9():632805. PubMed ID: 33644071
[TBL] [Abstract][Full Text] [Related]
2. Impaired self-renewal and increased colitis and dysplastic lesions in colonic mucosa of AKR1B8-deficient mice.
Shen Y; Ma J; Yan R; Ling H; Li X; Yang W; Gao J; Huang C; Bu Y; Cao Y; He Y; Wan L; Zu X; Liu J; Huang MC; Stenson WF; Liao DF; Cao D
Clin Cancer Res; 2015 Mar; 21(6):1466-76. PubMed ID: 25538260
[TBL] [Abstract][Full Text] [Related]
3. AKR1B8 deficiency drives severe DSS-induced acute colitis through invasion of luminal bacteria and activation of innate immunity.
Deng Q; Yao Y; Yang J; Khoshaba R; Shen Y; Wang X; Cao D
Front Immunol; 2022; 13():1042549. PubMed ID: 36518763
[TBL] [Abstract][Full Text] [Related]
4. Murine aldo-keto reductase family 1 subfamily B: identification of AKR1B8 as an ortholog of human AKR1B10.
Joshi A; Rajput S; Wang C; Ma J; Cao D
Biol Chem; 2010 Dec; 391(12):1371-8. PubMed ID: 21087085
[TBL] [Abstract][Full Text] [Related]
5. Aldo-keto reductase family 1 member B8 is secreted via non-classical pathway.
Tang Z; Xia C; Huang R; Li X; Wang WC; Guo W; Duan L; Luo W; Cao D; Luo DX
Int J Clin Exp Pathol; 2014; 7(7):3791-9. PubMed ID: 25120755
[TBL] [Abstract][Full Text] [Related]
6. Compensatory upregulation of aldo-keto reductase 1B10 to protect hepatocytes against oxidative stress during hepatocarcinogenesis.
Liu Y; Zhang J; Liu H; Guan G; Zhang T; Wang L; Qi X; Zheng H; Chen CC; Liu J; Cao D; Lu F; Chen X
Am J Cancer Res; 2019; 9(12):2730-2748. PubMed ID: 31911858
[TBL] [Abstract][Full Text] [Related]
7. Aldo-keto reductase 1B10 protects human colon cells from DNA damage induced by electrophilic carbonyl compounds.
Zu X; Yan R; Pan J; Zhong L; Cao Y; Ma J; Cai C; Huang D; Liu J; Chung FL; Liao DF; Cao D
Mol Carcinog; 2017 Jan; 56(1):118-129. PubMed ID: 26969882
[TBL] [Abstract][Full Text] [Related]
8. Aldo-keto reductase 1B10 as a Carcinogenic but Not a Prognostic Factor in Colorectal Cancer.
Ye X; Wang T; Zhong L; Farrés J; Xia J; Zeng X; Cao D
J Cancer; 2024; 15(6):1657-1667. PubMed ID: 38370384
[TBL] [Abstract][Full Text] [Related]
9. Aldo-Keto Reductases as Early Biomarkers of Hepatocellular Carcinoma: A Comparison Between Animal Models and Human HCC.
Torres-Mena JE; Salazar-Villegas KN; Sánchez-Rodríguez R; López-Gabiño B; Del Pozo-Yauner L; Arellanes-Robledo J; Villa-Treviño S; Gutiérrez-Nava MA; Pérez-Carreón JI
Dig Dis Sci; 2018 Apr; 63(4):934-944. PubMed ID: 29383608
[TBL] [Abstract][Full Text] [Related]
10. Substrate specificity and catalytic efficiency of aldo-keto reductases with phospholipid aldehydes.
Spite M; Baba SP; Ahmed Y; Barski OA; Nijhawan K; Petrash JM; Bhatnagar A; Srivastava S
Biochem J; 2007 Jul; 405(1):95-105. PubMed ID: 17381426
[TBL] [Abstract][Full Text] [Related]
11. Fucosylation Deficiency in Mice Leads to Colitis and Adenocarcinoma.
Wang Y; Huang D; Chen KY; Cui M; Wang W; Huang X; Awadellah A; Li Q; Friedman A; Xin WW; Di Martino L; Cominelli F; Miron A; Chan R; Fox JG; Xu Y; Shen X; Kalady MF; Markowitz S; Maillard I; Lowe JB; Xin W; Zhou L
Gastroenterology; 2017 Jan; 152(1):193-205.e10. PubMed ID: 27639802
[TBL] [Abstract][Full Text] [Related]
12. Aldo-keto reductase 1B10 promotes development of cisplatin resistance in gastrointestinal cancer cells through down-regulating peroxisome proliferator-activated receptor-γ-dependent mechanism.
Matsunaga T; Suzuki A; Kezuka C; Okumura N; Iguchi K; Inoue I; Soda M; Endo S; El-Kabbani O; Hara A; Ikari A
Chem Biol Interact; 2016 Aug; 256():142-53. PubMed ID: 27417252
[TBL] [Abstract][Full Text] [Related]
13. AKR1B10 (Aldo-keto reductase family 1 B10) promotes brain metastasis of lung cancer cells in a multi-organ microfluidic chip model.
Liu W; Song J; Du X; Zhou Y; Li Y; Li R; Lyu L; He Y; Hao J; Ben J; Wang W; Shi H; Wang Q
Acta Biomater; 2019 Jun; 91():195-208. PubMed ID: 31034948
[TBL] [Abstract][Full Text] [Related]
14. Aldo-Keto Reductase 1B10 and Its Role in Proliferation Capacity of Drug-Resistant Cancers.
Matsunaga T; Wada Y; Endo S; Soda M; El-Kabbani O; Hara A
Front Pharmacol; 2012; 3():5. PubMed ID: 22319498
[TBL] [Abstract][Full Text] [Related]
15. Baitouweng Decoction Ameliorates Ulcerative Colitis in Mice Partially Attributed to Regulating Th17/Treg Balance and Restoring Intestinal Epithelial Barrier.
Miao Z; Chen L; Feng H; Gu M; Yan J; Xu Y; Ye B
Front Pharmacol; 2020; 11():531117. PubMed ID: 33597862
[TBL] [Abstract][Full Text] [Related]
16. Probiotic mixture VSL#3 reduces colonic inflammation and improves intestinal barrier function in Muc2 mucin-deficient mice.
Kumar M; Kissoon-Singh V; Coria AL; Moreau F; Chadee K
Am J Physiol Gastrointest Liver Physiol; 2017 Jan; 312(1):G34-G45. PubMed ID: 27856417
[TBL] [Abstract][Full Text] [Related]
17. CD103+ CD11b+ Dendritic Cells Induce Th17 T Cells in Muc2-Deficient Mice with Extensively Spread Colitis.
Wenzel UA; Jonstrand C; Hansson GC; Wick MJ
PLoS One; 2015; 10(6):e0130750. PubMed ID: 26121642
[TBL] [Abstract][Full Text] [Related]
18. Characterization of AKR1B16, a novel mouse aldo-keto reductase.
Giménez-Dejoz J; Weber S; Barski OA; Möller G; Adamski J; Parés X; Porté S; Farrés J
Chem Biol Interact; 2017 Oct; 276():182-193. PubMed ID: 28322781
[TBL] [Abstract][Full Text] [Related]
19. Effect of toll-like receptor 3 agonist poly I:C on intestinal mucosa and epithelial barrier function in mouse models of acute colitis.
Zhao HW; Yue YH; Han H; Chen XL; Lu YG; Zheng JM; Hou HT; Lang XM; He LL; Hu QL; Dun ZQ
World J Gastroenterol; 2017 Feb; 23(6):999-1009. PubMed ID: 28246473
[TBL] [Abstract][Full Text] [Related]
20. Effects of hypoxic exposure on immune responses of intestinal mucosa to Citrobacter colitis in mice.
Ji Q; Zhang Y; Zhou Y; Gamah M; Yuan Z; Liu J; Cao C; Gao X; Zhang H; Ren Y; Zhang W
Biomed Pharmacother; 2020 Sep; 129():110477. PubMed ID: 32768962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
